Speaker illustration

Doctor Samuel Sherratt

University of New Hampshire, Beverly (United States of America)

Eicosapentaenoic acid (EPA) reduced expression of neutrophil activation proteins in endothelial cells during challenge with angiotensin II (Ang II) and cytokines

Event: ESC Preventive Cardiology 2023

Topic: Leukocytes, Inflammation, Immunity

Session: Primary Care and Risk Factor Management 1

Thumbnail

Eicosapentaenoic acid (EPA) treatment increased the ratio to arachidonic (EPA/AA) and reduced adhesion molecule expression in vascular endothelium during inflammation

Event: ESC Preventive Cardiology 2023

Topic: Lipids, Metabolism

Session: Primary Care and Risk Factor Management 1

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb